1. Home
  2. CPF vs RCUS Comparison

CPF vs RCUS Comparison

Compare CPF & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPF
  • RCUS
  • Stock Information
  • Founded
  • CPF 1954
  • RCUS 2015
  • Country
  • CPF United States
  • RCUS United States
  • Employees
  • CPF N/A
  • RCUS N/A
  • Industry
  • CPF Major Banks
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPF Finance
  • RCUS Health Care
  • Exchange
  • CPF Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • CPF 714.5M
  • RCUS 727.1M
  • IPO Year
  • CPF N/A
  • RCUS 2018
  • Fundamental
  • Price
  • CPF $26.70
  • RCUS $8.44
  • Analyst Decision
  • CPF Buy
  • RCUS Buy
  • Analyst Count
  • CPF 1
  • RCUS 11
  • Target Price
  • CPF $30.00
  • RCUS $25.67
  • AVG Volume (30 Days)
  • CPF 164.5K
  • RCUS 1.2M
  • Earning Date
  • CPF 04-23-2025
  • RCUS 05-06-2025
  • Dividend Yield
  • CPF 4.01%
  • RCUS N/A
  • EPS Growth
  • CPF 4.40
  • RCUS N/A
  • EPS
  • CPF 2.14
  • RCUS N/A
  • Revenue
  • CPF $247,706,000.00
  • RCUS $141,000,000.00
  • Revenue This Year
  • CPF N/A
  • RCUS N/A
  • Revenue Next Year
  • CPF $17.75
  • RCUS $25.77
  • P/E Ratio
  • CPF $12.57
  • RCUS N/A
  • Revenue Growth
  • CPF 5.37
  • RCUS N/A
  • 52 Week Low
  • CPF $19.52
  • RCUS $6.50
  • 52 Week High
  • CPF $33.25
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • CPF 57.75
  • RCUS 53.47
  • Support Level
  • CPF $25.23
  • RCUS $7.06
  • Resistance Level
  • CPF $27.10
  • RCUS $9.35
  • Average True Range (ATR)
  • CPF 0.83
  • RCUS 0.54
  • MACD
  • CPF 0.19
  • RCUS 0.09
  • Stochastic Oscillator
  • CPF 50.91
  • RCUS 72.05

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: